Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 5, 2007, Boehringer Ingelheim Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
|Methadone Intermediate (9254)||II|
|Dextropropoxyphene, bulk (non-dosage forms) (9273)||II|
The company plans to manufacture the listed controlled substances in bulk for sale to its customers for formulation into finished pharmaceuticals.
Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 2401 Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed no later than October 26, 2007.Start Signature
Dated: August 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administraton, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E7-16855 Filed 8-24-07; 8:45 am]
BILLING CODE 4410-09-P